Latest evidence-based view
SPHB · HOLD
SPHB (Invesco S&P 500 High Beta) reweights stocks by momentum, quality, value or another systematic factor. One-month (-0.12%) and three-month (-5.87%) evidence is not decisive enough for a directional call.
SPHB currently supports a wait stance.
One-month (-0.12%) and three-month (-5.87%) evidence is not decisive enough for a directional call.
The opposing case is clear: A factor regime change can cause prolonged relative underperformance. The 0.25% annual expense ratio is deducted throughout ownership. The stance remains tied to the observed price trend.
Use staged sizing and reassess when the one- and three-month trends no longer support this stance.